Stay updated on Sipuleucel-T Manufacturing Clinical Trial

Sign up to get notified when there's something new on the Sipuleucel-T Manufacturing Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sipuleucel-T Manufacturing Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study evaluating sipuleucel-T manufacturing for European men with metastatic castration-resistant prostate cancer. It includes the study’s eligibility criteria, participating locations, treatment plan, outcomes, and record dates.
    Difference
    45%
    Check dated 2026-11-08T00:32:04.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision number changed from v3.7.2 to v3.8.0 on the 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-31T18:37:16.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    A banner announces NIH’s transition from the term “Artificial Intelligence” to “Super Intelligence” and links to transition updates and FAQs.
    Difference
    1%
    Check dated 2026-10-24T20:24:20.000Z thumbnail image
  5. Check
    28 days ago
    Change Detected
    Summary
    The displayed ClinicalTrials.gov revision identifier changed from v3.7.1 to v3.7.2 while the study record remains inaccessible.
    Difference
    0.2%
    Check dated 2026-10-17T22:11:35.000Z thumbnail image
  6. Check
    35 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T22:08:30.000Z thumbnail image
  7. Check
    56 days ago
    Change Detected
    Summary
    The page now shows a 403 Forbidden error, replacing the expected study record content. The error indicates the page is currently inaccessible due to access restrictions.
    Difference
    17%
    Check dated 2026-09-19T22:07:37.000Z thumbnail image

Stay in the know with updates to Sipuleucel-T Manufacturing Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sipuleucel-T Manufacturing Clinical Trial page.